Hints and tips:
Related Special Reports
...It is part of a broader network, formerly known as Underwriters Laboratories, that also includes an organisation focused on safety research and one that creates safety standards....
...Roche will pay $7.1bn upfront and a near-term milestone payment of $150mn. Pfizer will keep the commercialisation rights outside the US and Japan....
...Consider how Roche spent its cash. It acquired obesity drug developer Carmot Therapeutics for $2.7bn....
...The Cupertino-based company last week announced it was upgrading its Shanghai research centre and opening a laboratory in Shenzhen to work on research and testing for its iPhone, iPad and Vision Pro product...
...Consumers bought nearly 80,000 battery-powered vehicles in January, a 19 per cent increase from the 66,000 they purchased in January 2023, according to data from Argonne National Laboratory....
...Such software is part of the new and growing sector of “collaborative work management”, where providers include Asana and Monday.com....
...Researchers from the University of California, Berkeley and the Lawrence Berkeley National Laboratory have already used the findings as part of experimental efforts to create new materials, according to...
...The active ingredient is used in La Roche Posay’s Lipikar Eczema Med cream....
...Patients must have their stem cells extracted from their bone marrow so their genes can be edited in a laboratory....
...The drugmakers Pfizer and Roche said they are piloting use of rFC at some of their facilities....
...The top five contributors to the fund’s performance last year were Meta Platforms, Microsoft, Novo Nordisk, L’Oréal and IDEXX Laboratories....
...The medical device and healthcare company Abbott Laboratories, based on Chicago’s farther outskirts, has leased offices in the city’s most famous downtown skyscraper, the Willis Tower....
...It added that “having invested in the best state of the art equipment available”, Sotheby’s will “continue to analyse property in its own laboratories and is moving to an arrangement that is best suited...
...Dean Li, president of Merck’s research laboratories, praised the UK’s scientific talent and expertise, hoping that the investment in King’s Cross will help researchers at MSD, known as Merck in the US, work...
...He said he would remain on the faculty of Stanford and pursue his research, although he would further tighten controls in his laboratory, which is named after him....
...The most prominent mainstream scientific organisation outside Asia that publicly opposes the Fukushima release is the US National Association of Marine Laboratories....
...Also, Office for National Statistics House Price Index US: Federal Reserve publishes the Beige Book Results: ABB Q3, Abbott Laboratories Q3, Alcoa Q3, ASML Q3, Barratt Developments trading update and AGM...
...Collin Roche, co-chief executive of GTCR, said in a statement that the firm had “tremendous confidence in the opportunity for sustained, long-term growth at Worldpay”....
...Taking advantage of decades of laboratory research on lithium-ion batteries, the Japanese company was able to introduce products such as mobile phones and handheld video cameras that have changed the lives...
...Roche told the Financial Times it was reviewing its legal and policy options regarding the “negative impacts of IRA on patients and innovation”....
...“If we see something large that is attractive, we can chase it, but we don’t feel pressure to do that,” Roche told DD in an interview....
...When the US drugs company Abbott Laboratories acquired a small division of the German chemicals group BASF for $6.9bn 23 years ago, its shares fell on fears that it had overpaid....
...Halks-Miller, who left Illumina to join Grail as its founding laboratory director, said her big concern was that the “political wrangling” with the EU and Icahn could cause Grail to struggle for funding...
...Other competitors such as Exact Sciences, based in Wisconsin, and San Francisco’s Freenome, a start-up backed by Roche, are racing to launch their own tests....
...Illumina was the fourth-largest spender on lobbying among biotech and pharma companies in 2022 at $9.4mn, behind only Pfizer, Roche and Amgen, which are much larger companies, according to an analysis by...
International Edition